<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Thirty-seven patients with advanced non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> who were treated by total-body irradiation (TBI) at the Royal Marsden Hospital are reviewed </plain></SENT>
<SENT sid="1" pm="."><plain>Twenty-four patients had received no previous therapy; 13 patients were in relapse </plain></SENT>
<SENT sid="2" pm="."><plain>The overall response rate was 73% for nodular <z:hpo ids='HP_0002665'>lymphomas</z:hpo> and 80% for those with diffuse disease </plain></SENT>
<SENT sid="3" pm="."><plain>THe duration of complete response ranged from two to 41 months (median 12 months) </plain></SENT>
<SENT sid="4" pm="."><plain>Subsequent chemotherapy was given successfully except in patients with prolonged <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> which appeared to be related to an initially involved bone marrow </plain></SENT>
<SENT sid="5" pm="."><plain>Hemibody irradiation (HBI) was the least myelosuppressive form of TBI and is now being used in complete remission following chemotherapy </plain></SENT>
</text></document>